![Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1557414560/truvada.jpg?VersionId=HRmBaz_VBQE1Fq1Tzvg00gT.5aWTnKsM)
Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma
Mike Stuber on Twitter: "Size comparison of #Truvada & #Descovy - smaller size and improved renal/bone profile #HIV #pharmacists #ARV https://t.co/FatWlCb0Mq" / Twitter
![New Resource from SFAF: Which PrEP medication is best for me? Truvada and Descovy Comparison – Getting to Zero SF New Resource from SFAF: Which PrEP medication is best for me? Truvada and Descovy Comparison – Getting to Zero SF](https://gettingtozerosf.org/wp-content/uploads/2020/03/Truvada-v-Descovy-SFAF-snip-446x480.jpg)